DAXOR

About:

DAXOR Corporation is an innovative medical instrumentation and biotechnology company.

Website: http://daxor.com

Twitter/X: daxorbva

Top Investors: National Institutes of Health, Launch Tennessee

Description:

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

Total Funding Amount:

$13.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

1970-01-01

Contact Email:

info(AT)daxor.com

Founders:

Joseph Feldschuh

Number of Employees:

1-10

Last Funding Date:

2024-09-05

IPO Status:

Public

Industries:

© 2025 bioDAO.ai